journal article·2022-07-27Open access

Fe3O4-PAA–(HP-γ-CDs) Biocompatible Ferrimagnetic Nanoparticles for Increasing the Efficacy in Superparamagnetic Hyperthermia

Costica Caizer, Isabela Simona Caizer, Roxana Racoviceanu, Claudia Geanina Watz, Marius Mioc, Cristina Adriana Dehelean, Tiberiu Bratu, Codruța Soica

Nanomaterials· Volume 12· Issue 15

Abstract

In this paper, we present the obtaining of Fe3O4-PAA–(HP-γ-CDs) ferrimagnetic nanobioconjugates (PAA: polyacrylic acid, HP-γ-CDs: hydroxypropyl gamma-cyclodextrins) in a hybrid core-shell biostructure (core: inorganic Fe3O4 nanoparticles, and shell: organic PAA–(HP-γ-CDs)) and their use in superparamagnetic hyperthermia without cellular toxicity and with increased efficacy for future alternative cancer therapy. In order to design the optimal experimental conditions for obtaining nanobioconjugates and then superparamagnetic hyperthermia (SPMHT), we used molecular docking simulation and computational assessment of the maximum specific loss power (SLP) that led to nanoparticles’ heating. The nanoparticles and nanobioconjugates obtained were studied and characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), Fourier transformed-infrared spectroscopy (FT-IR), dynamic light scattering (DLS), and magnetic measurements (MMs). The cell viability of the nanoparticles and nanobioconjugates was assessed by means of the MTT assay using human immortalized keratinocytes (HaCaT) as an in vitro model. Superparamagnetic hyperthermia with nanoparticles and nanobioconjugates was obtained experimentally in a magnetic field of 15.92 kA/m and frequency of 312.2 kHz for the magnetic nanoparticle core with a (average) diameter of 15.8 nm, which resulted in the maximum hyperthermic effect that led to a temperature of ~42.5 °C necessary in the therapy of tumors in a short time so as not to affect healthy tissues. The biological screening of Fe3O4-PAA nanoparticles and PAA–(HP-γ-CDs) nanobioconjugates showed no cytotoxic effect on HaCaT cells for a time interval of 24 h, both under standard (37 °C) and hyperthermia conditions (42.5 °C). Thus, Fe3O4-PA–(HP-γ-CDs) ferrimagnetic nanobioconjugates can be used successfully in superparamagnetic hyperthermia without toxicity and with increased efficiency due to the small layer thickness of the PAA–(HP-γ-CDs) shell, which is suitable in this alternative therapeutic technique.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Iron oxide chemistry and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physics, Faculty of Physics, West University of Timisoara, 300223 Timisoara, Romania

Department of Plastic and Reconstructive Surgery, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania

Department of Clinical Practical Skills, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania

Research Centre for Pharmaco-Toxicological Evaluation, “Victor Babes” University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania

Department of Pharmaceutical Physics, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy of Timisoara, 300041 Timisoara, Romania

Funding

Ministry of Research, Innovation and Digitization · West University of Timisoara

References (77)

Show source-provided references
1. Spirou, S.V., Costa Lima, S.A., Bouziotis, P., Vranješ-Djurić, S., Efthimiadou, E.K., Laurenzana, A., Barbosa, A.I., Garcia-Alonso, I., Jones, C., and Jankovic, D. (2018). Recommendations for in vitro and in vivo testing of magnetic nanoparticle hyperthermia combined with radiation therapy. Nanomaterials, 8.10.3390/nano8050306 ↗
2. Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy10.7150/thno.40805 ↗
3. Review on magnetic nanoparticle-mediated hyperthermia for cancer therapy10.1007/s11051-020-05045-9 ↗
4. Magnetic nanoparticles for hyperthermia in cancer treatment: An emerging tool10.1007/s11356-019-07231-2 ↗
5. Iacovita, C., Fizeșan, I., Pop, A., Scorus, L., Dudric, R., Stiufiuc, G., Vedeanu, N., Tetean, R., Loghin, F., and Stiufiuc, R. (2020). In vitro intracellular hyperthermia of iron oxide magnetic nanoparticles, synthesized at high temperature by a polyol process. Pharmaceutics, 12.10.3390/pharmaceutics12050424 ↗
6. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers10.1016/j.addr.2020.06.005 ↗
7. Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer10.1016/j.msec.2019.01.066 ↗
8. Using PEGylated magnetic nanoparticles to describe the EPR effect in tumor for predicting therapeutic efficacy of micelle drugs10.1039/C7NR08319J ↗
9. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies10.1186/1743-8977-7-36 ↗
10. Current status of nanomedicine in the chemotherapy of breast cancer10.1007/s00280-019-03910-6 ↗
11. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges10.1016/j.nano.2015.10.019 ↗
12. Construction of small-sized superparamagnetic Janus nanoparticles and their application in cancer combined chemotherapy and magnetic hyperthermia10.1039/C9BM01880H ↗
13. Shen, L., Li, B., and Qiao, Y. (2018). Fe3O4 nanoparticles in targeted drug/gene delivery systems. Materials, 11.10.3390/ma11020324 ↗
14. Functional magnetic particles for medical application
15. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles10.1002/ijc.21061 ↗
16. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma10.1007/s11060-005-9059-z ↗
17. Optimizing magnetic nanoparticle design for nanothermotherapy10.2217/17435889.3.6.831 ↗
18. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy10.1021/nn201290k ↗
19. Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes10.1021/nn506949t ↗
20. Injectable and thermally contractible hydroxypropyl methyl cellulose/Fe3O4 for magnetic hyperthermia ablation of tumors10.1016/j.biomaterials.2017.03.004 ↗
21. “All-in-One” Nanoparticles for trimodality imaging-guided intracellular photo-magnetic hyperthermia therapy under intravenous administration10.1002/adfm.201705710 ↗
22. Rai, M., and Jamil, B. (2019). Magnetic/Superparamagnetic hyperthermia as an effective noninvasive alternative method for therapy of malignant tumors. Nanotheranostics: Applications and Limitations, Springer.
23. Caizer, C. (2021). Optimization study on specific loss power in superparamagnetic hyperthermia with magnetite nanoparticles for high efficiency in alternative cancer therapy. Nanomaterials, 11.10.3390/nano11010040 ↗
24. Comparative evaluation of heating ability and biocompatibility of different ferrite-based magnetic fluids for hyperthermia application10.1002/jbm.b.30630 ↗
25. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery10.1016/j.addr.2011.03.008 ↗
26. Study on the efficiency of nanosized magnetite and mixed ferrites in magnetic hyperthermia10.1007/s10856-014-5187-3 ↗
27. Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs–PEG–HER in HER2+ human breast cancer cells10.1088/0957-4484/27/10/105601 ↗
28. Synthesis of ferromagnetic Fe0.6Mn0.4O nanofl owers as a new class of magnetic theranostic platform for in vivo T1-T2 Dual-Mode magnetic resonance imaging and magnetic hyperthermia therapy10.1002/adhm.201600357 ↗
29. Caizer, C. (2021). Theoretical study on specific loss power and heating temperature in CoFe2O4 nanoparticles as possible candidate for alternative cancer therapy by superparamagnetic hyperthemia. Appl. Sci., 11.10.3390/app11125505 ↗
30. Caizer, C. (2021). Computational study regarding CoxFe3-xO4 ferrite nanoparticles with tunable magnetic properties in superparamagnetic hyperthermia for effective alternative cancer therapy. Nanomaterials, 11.10.3390/nano11123294 ↗
31. Magnetic particle hyperthermia: Nanoparticle magnetism and materials development for cancer therapy10.1088/0953-8984/18/38/S26 ↗
32. Rai, M., and Shegokar, R. (2017). Magnetic hyperthermia-using magnetic metal/oxide nanoparticles with potential in cancer therapy. Metal Nanoparticles in Pharma, Springer.
33. Cullity, B.D., and Graham, C.D. (2009). Introduction to Magnetic Materials, John Wiley & Sons, Inc.. [2nd ed.].10.1002/9780470386323 ↗
34. Valenzuela, R. (1994). Magnetic Ceramics, Cambridge University Press.10.1017/CBO9780511600296 ↗
35. Caizer, C., and Rai, M. (2022). Magnetic nanoparticles in alternative tumors therapy: Biocompatibility, toxicity and safety compared with classical methods. Magnetic Nanoparticles in Human Health and Medicine: Current Medical Applications and Alternative Therapy of Cancer, Wiley.10.1002/9781119754725.ch16 ↗
36. Rai, M., and Shegokar, R. (2017). Biocompatible magnetic oxide nanoparticles with metal ions coated with organic shell as potential therapeutic agents in cancer. Metal Nanoparticles in Pharma, Springer International Publishing.
37. Introduction and general overview of cyclodextrin chemistry10.1021/cr970022c ↗
38. Caizer, C., and Rai, M. (2022). Classical magnetoliposomes vs current magnetociclodextrins with ferrimagnetic nanoparticle for high efficiency and low toxicity in alternative therapy of cancer by magnetic/superparamagnetic hyperthermia. Magnetic Nanoparticles in Human Health and Medicine: Current Medical Applications and Alternative Therapy of Cancer, Wiley.10.1002/9781119754725.ch13 ↗
39. Wimmer, T.C. (2011). Ullmann’s Encyclopedia of Industrial Chemistry, Wiley-VCH.
40. Cyclodextrin Drug Carrier Systems10.1021/cr970025p ↗
41. Macrocycles as drug-enhancing excipients in pharmaceutical formulations10.1007/s10847-021-01055-9 ↗
42. Magnetic behavior of Mn0.6Fe0.4Fe2O4 nanopartciles in ferrofluid at low temperatures10.1016/S0304-8853(02)00701-1 ↗
43. Magnetic properties of the novel nanocomposite (Zn0.15Ni0.85Fe2O4)0.15/(SiO2)0.85 at room temperature10.1016/j.jmmm.2007.10.012 ↗
44. Caizer, C., and Caizer, I.S. (2021). Study on maximum specific loss power in Fe3O4 nanoparticles decorated with biocompatible gamma-cyclodextrins for cancer therapy with superparamagnetic hyperthermia. Int. J. Molec. Sci., 22.10.3390/ijms221810071 ↗
45. AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization and Multithreading10.1002/jcc.21334 ↗
46. Smit, J., and Wijin, H.P.J. (1961). Les Ferites, Bibl. Tehn. Philips.
47. Modeling the performance of magnetic nanoparticles in multimodal cancer therapy10.1063/1.3432757 ↗
48. Superparamagnetism10.1063/1.2185850 ↗
49. Magnétisme et théorie des électrons
50. Fine particles, thin films and exchange anisotropy
51. Théorie du traînage magnétique des ferromagnétiques en grains fins avec application aux terres cuites
52. Thermal fluctuations of a single-domain particle10.1103/PhysRev.130.1677 ↗
53. Magnetization reversal in ultrashort magnetic field pulses10.1103/PhysRevLett.81.3251 ↗
54. Synthesis of Nanocomposition of Poly Acrylic Acid/Chitosan Coated-Magnetite Nanoparticles to Investigation of Interaction with BSA and IGG Proteins10.17352/2455-3492.000018 ↗
55. Formation and Surface Modification of Fe3O4 Nanoparticles by Co-Precipitation and Sol-Gel Method
56. T2 law for magnetite-based ferrofluids10.1088/0953-8984/15/6/303 ↗
57. Thermosensitive betulinic acid-loaded magnetoliposomes: A promising antitumor potential for highly aggressive human breast adenocarcinoma cells under hyperthermic conditions10.2147/IJN.S269630 ↗
58. A Facile One-Pot Synthesis of Poly(Acrylic Acid)-Functionalized Magnetic Iron Oxide Nanoparticles for Suppressing Reactive Oxygen Species Generation and Adsorption of Biocatalyst10.1088/2053-1591/ab5be1 ↗
59. Selective Synthesis of Fe2O3 and Fe3O4 Nanowires via a Single Precursor: A General Method for Metal Oxide Nanowires10.1007/s11671-010-9641-y ↗
60. Synthesis, Surface Modification and Characterisation of Biocompatible Magnetic Iron Oxide Nanoparticles for Biomedical Applications10.3390/molecules18077533 ↗
61. Moacă, E.-A., Ciprian-Valentin, M., Ioana-Gabriela, M., Roxana, R., Codruţa, Ş., Cristina-Adriana, D., Cornelia, P., and Sorin, F. (2019). Fe3O4@C Matrix with Tailorable Adsorption Capacities for Paracetamol and Acetylsalicylic Acid: Synthesis, Characterization, and Kinetic Modeling. Molecules, 24.10.3390/molecules24091727 ↗
62. Cursaru, L.M., Roxana, M.P., Dumitru, V.D., Robert, M., Caroline, T., Marie, C., Hélène, J., and Bernard, D. (2020). One-step Soft Chemical Synthesis of Magnetite Nanoparticles under Inert Gas Atmosphere. Magnetic Properties and In Vitro Study. Nanomaterials, 10.10.3390/nano10081500 ↗
63. Characterization of Modified Magnetite Nanoparticles for Albumin Immobilization10.1155/2014/705068 ↗
64. In Situ FTIR-ATR Examination of Poly(Acrylic Acid) Adsorbed onto Hematite at Low PH10.1021/la027012d ↗
65. Kneller, E. (1962). Ferromagnetismus, Springer-Verlag.10.1007/978-3-642-86695-1 ↗
66. Conjugation of cyclodextrin to magnetic Fe3O4 nanoparticles via polydopamine coating for drug delivery10.1016/j.porgcoat.2017.10.007 ↗
67. Noncollinear spin srrangement in ultrafine ferrimagnetic crystallites10.1103/PhysRevLett.27.1140 ↗
68. Surface spin disorder in NiFe2O4 nanoparticles10.1103/PhysRevLett.77.394 ↗
69. Anomalous properties of magnetic nanoparticles10.1016/S0304-8853(98)00845-2 ↗
70. Development of Carvedilol-Cyclodextrin Inclusion Complexes Using Fluid-Bed Granulation: A Novel Solid-State Complexation Alternative with Technological Advantages10.1111/jphp.12601 ↗
71. Novel Water-Soluble Fisetin/Cyclodextrins Inclusion Complexes: Preparation, Characterization, Molecular Docking and Bioavailability10.1016/j.carres.2015.09.013 ↗
72. Inclusion Complexes of β-Cyclodextrine with Fe3O4@HA@Ag Part I: Preparation and Characterization10.35530/IT.070.03.1548 ↗
73. Singh, S.V.B. (2022, March 10). Water Soluble Complexes of Curcumin and Hydroxypropyl Cyclodextrins: Preparation and Characterization. SREE Chitra Tirunal Institute for Medical Sciences and Technology. Available online: http://docplayer.net/58922173-Water-soluble-complexes-of-curcumin-and-hydroxypropyl-cyclodextrins-preparation-and-characterization-s-v-berwin-singh.
74. (2009). Reviewed and Confirmed in 2017, Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro Cytotoxicity. ISO Catalogue, Edition 3. (Standard No. ISO 10993-5:2009). Available online: https://www.iso.org/standard/36406.html.
75. Medical application of functionalized magnetic nanoparticles10.1263/jbb.100.1 ↗
76. Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy10.1016/j.jmmm.2006.10.1156 ↗
77. Vilas-Boas, V., Carvalho, F., and Espiña, B. (2020). Magnetic hyperthermia for cancer treatment: Main parameters affecting the outcome of in vitro and in vivo studies. Molecules, 25.10.3390/molecules25122874 ↗